You are on our international English website. This site features our entire product portfolio worldwide. The products featured may not be available in the US. If you are a citizen from the US, please visit your country website for local information and contacts.
Medical Technology for healthcare professionals
Global website (English)
back
Medical Technology
recommended searches
popular searches
Intelligently Illuminating
PRODUCT

Intelligently Illuminating

AI-guided OCT image assessment with CIRRUS PathFinder

CIRRUS PathFinder1,2 is a fully integrated deep learning, AI-based support tool that enables more confident decision-making with OCT interpretation assistance. Designed to complement your clinical workflow, CIRRUS PathFinder streamlines the review of macular OCT scans by automatically identifying scans that may need closer review.

Contact Us
  • Illuminating
  • Intelligently
  • Integrated

Know when to take a closer look

Third-party Content Blocked

The video player is blocked due to your cookie preferences. To change the settings and play the video, please click the button below and consent to use of "Functional" tracking technologies.

Illuminating

  • Enhanced OCT scan interpretation provides improved workflow efficiency.
  • Automatic image assessment highlights poor-quality scans.
  • AI-enabled detection identifies OCT B-scans with macular findings such as Subretinal fluid (SRF), intraretinal fluid, retinal pigment epithelium atrophy, retinal pigment epithelium elevation, disruption of inner retinal layers, disruption of the vitreoretinal interface, inner segment/outer segment disruption.
Intelligent

Intelligent

  • Employs deep-learning AI algorithms for increased confidence and clinical support.
  • Fellow eye monitoring effortlessly tracks for changes.
  • Trained on more than 75,000 OCT B-scan images.
  • Validated by leading retina specialists to have 88% sensitivity and 93% specificity3.
Integrated

Integrated

  • Works seamlessly with CIRRUS review software.
  • Can be switched on and off as required (e.g., for educational purposes).
  • Empowers imagers and clinicians to capture detailed scans in undiagnosed areas.
  • Provides an efficient solution for reviewing large amounts of detailed data.

Third-party Content Blocked

The video player is blocked due to your cookie preferences. To change the settings and play the video, please click the button below and consent to use of "Functional" tracking technologies.

How it works

CIRRUS PathFinder detects B-scans of interest within the CIRRUS Macular Cube
  • Acquire: Capture dense 512 x 128 Smart Cube scans of the macula, automatically centered on the fovea.
  • Qualify: Assesses image quality via machine learning—performs good and poor image quality assessment.
  • Detect: Determines if images are of interest with presence of eight pathologies or conditions.
  • Flag: Highlights poor quality image (yellow) and B-scan of interest (red).

Videos

  • Third-party Content Blocked

    The video player is blocked due to your cookie preferences. To change the settings and play the video, please click the button below and consent to use of "Functional" tracking technologies.

Downloads

Get in touch with us!

Receive more information about the product and availability in your country!

Form is loading...

Personal contact information

If you want to have more information on data processing at ZEISS please refer to our data privacy notice. 

Available services

ZEISS OPTIME Service Plans

Enabling you to focus on patient care.

Make a sales request

Any questions about buying our products?

Click here

to get direct assistance from our service team.

Stay up to date

Sign up for updates on current topics, news and events.
  • 1

    PathFinder is available on all ZEISS CIRRUS devices.
  • 2

    Pending CE mark.
  • 3

    Talcott E, Valentim C, Perkins S, Ren H, Manivannan N, Zhang Q, Bagherinia H, Lee G, Yu S, D’Souza N, Jarugula H, Patel K, Singh R. Automated Detection of Abnormal Optical Coherence Tomography B-scans Using a Deep Learning Artificial Intelligence Neural Network Platform. Int Ophthalmol Clin. 2024 Jan;64(1):115-127.